These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 15526170
1. Modulation of SMN nuclear foci and cytoplasmic localization by its C-terminus. Hua Y, Zhou J. Cell Mol Life Sci; 2004 Oct; 61(19-20):2658-63. PubMed ID: 15526170 [Abstract] [Full Text] [Related]
3. Distinct domains of the spinal muscular atrophy protein SMN are required for targeting to Cajal bodies in mammalian cells. Renvoisé B, Khoobarry K, Gendron MC, Cibert C, Viollet L, Lefebvre S. J Cell Sci; 2006 Feb 15; 119(Pt 4):680-92. PubMed ID: 16449324 [Abstract] [Full Text] [Related]
4. Targeting of SMN to Cajal bodies is mediated by self-association. Morse R, Shaw DJ, Todd AG, Young PJ. Hum Mol Genet; 2007 Oct 01; 16(19):2349-58. PubMed ID: 17635841 [Abstract] [Full Text] [Related]
5. The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells. Young PJ, Le TT, thi Man N, Burghes AH, Morris GE. Exp Cell Res; 2000 May 01; 256(2):365-74. PubMed ID: 10772809 [Abstract] [Full Text] [Related]
6. ZPR1 is essential for survival and is required for localization of the survival motor neurons (SMN) protein to Cajal bodies. Gangwani L, Flavell RA, Davis RJ. Mol Cell Biol; 2005 Apr 01; 25(7):2744-56. PubMed ID: 15767679 [Abstract] [Full Text] [Related]
7. Unrip, a factor implicated in cap-independent translation, associates with the cytosolic SMN complex and influences its intracellular localization. Grimmler M, Otter S, Peter C, Müller F, Chari A, Fischer U. Hum Mol Genet; 2005 Oct 15; 14(20):3099-111. PubMed ID: 16159890 [Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy. Thurmond J, Butchbach ME, Palomo M, Pease B, Rao M, Bedell L, Keyvan M, Pai G, Mishra R, Haraldsson M, Andresson T, Bragason G, Thosteinsdottir M, Bjornsson JM, Coovert DD, Burghes AH, Gurney ME, Singh J. J Med Chem; 2008 Feb 14; 51(3):449-69. PubMed ID: 18205293 [Abstract] [Full Text] [Related]
9. Analysis of mutations in the tudor domain of the survival motor neuron protein SMN. Mohaghegh P, Rodrigues NR, Owen N, Ponting CP, Le TT, Burghes AH, Davies KE. Eur J Hum Genet; 1999 Jul 14; 7(5):519-25. PubMed ID: 10439956 [Abstract] [Full Text] [Related]
10. Nuclear gems and Cajal (coiled) bodies in fetal tissues: nucleolar distribution of the spinal muscular atrophy protein, SMN. Young PJ, Le TT, Dunckley M, Nguyen TM, Burghes AH, Morris GE. Exp Cell Res; 2001 May 01; 265(2):252-61. PubMed ID: 11302690 [Abstract] [Full Text] [Related]
11. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy. DiMatteo D, Callahan S, Kmiec EB. Exp Cell Res; 2008 Feb 15; 314(4):878-86. PubMed ID: 18078930 [Abstract] [Full Text] [Related]
12. A role for complexes of survival of motor neurons (SMN) protein with gemins and profilin in neurite-like cytoplasmic extensions of cultured nerve cells. Sharma A, Lambrechts A, Hao le T, Le TT, Sewry CA, Ampe C, Burghes AH, Morris GE. Exp Cell Res; 2005 Sep 10; 309(1):185-97. PubMed ID: 15975577 [Abstract] [Full Text] [Related]
13. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Jarecki J, Chen X, Bernardino A, Coovert DD, Whitney M, Burghes A, Stack J, Pollok BA. Hum Mol Genet; 2005 Jul 15; 14(14):2003-18. PubMed ID: 15944201 [Abstract] [Full Text] [Related]
14. Construction of a plasmid containing human SMN, the SMA determining gene, coupled to EGFP. Arnold AS, Gueye M, Rondé P, Warter JM, Poindron P, Gies JP. Plasmid; 2002 Mar 15; 47(2):79-87. PubMed ID: 11982329 [Abstract] [Full Text] [Related]
15. The survival motor neuron (SMN) protein: effect of exon loss and mutation on protein localization. Le TT, Coovert DD, Monani UR, Morris GE, Burghes AH. Neurogenetics; 2000 Sep 15; 3(1):7-16. PubMed ID: 11085591 [Abstract] [Full Text] [Related]
16. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector. Baughan T, Shababi M, Coady TH, Dickson AM, Tullis GE, Lorson CL. Mol Ther; 2006 Jul 15; 14(1):54-62. PubMed ID: 16580882 [Abstract] [Full Text] [Related]
17. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy. Vezain M, Saugier-Veber P, Melki J, Toutain A, Bieth E, Husson M, Pedespan JM, Viollet L, Pénisson-Besnier I, Fehrenbach S, Bou J, Frébourg T, Tosi M. Eur J Hum Genet; 2007 Oct 15; 15(10):1054-62. PubMed ID: 17609673 [Abstract] [Full Text] [Related]
18. An intronic element contributes to splicing repression in spinal muscular atrophy. Kashima T, Rao N, Manley JL. Proc Natl Acad Sci U S A; 2007 Feb 27; 104(9):3426-31. PubMed ID: 17307868 [Abstract] [Full Text] [Related]
19. Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein. Hebert MD, Szymczyk PW, Shpargel KB, Matera AG. Genes Dev; 2001 Oct 15; 15(20):2720-9. PubMed ID: 11641277 [Abstract] [Full Text] [Related]
20. Regions essential for the interaction between Bcl-2 and SMN, the spinal muscular atrophy disease gene product. Sato K, Eguchi Y, Kodama TS, Tsujimoto Y. Cell Death Differ; 2000 Apr 15; 7(4):374-83. PubMed ID: 10773822 [Abstract] [Full Text] [Related] Page: [Next] [New Search]